"We'll figure it out together" — famous last words

One of the costliest mistakes medical device companies make is choosing ERP software whose implementation team has never actually walked a client through FDA approval. The vendor's consultants understand inventory. They understand production planning. They can configure a multi-level BOM with their eyes closed.

Then the questions start. How should the Design History File be structured to support a 510(k) submission? Where do CAPA records live, and how do they link to nonconformances and complaint records? How does the system enforce 21 CFR Part 11 electronic signature requirements during an audit? What does the configuration look like for full forward and backward lot traceability through a sterilization cycle?

If the consultant in the room has never sat across from an FDA investigator, you get blank stares and a polite promise to "figure it out together." Figuring it out on your timeline, at your expense, on the runway you're paying for — is not a partnership. It's tuition.

The bill for an inexperienced implementation team is rarely a single number. It's a thousand small ones that add up.

Configuration that has to be redone six months in, because the original setup didn't anticipate Part 820 requirements. Custom code written to work around the lack of standard quality modules — code that becomes a maintenance and validation burden forever. Re-training because the workflows the consultants designed don't match how an FDA-compliant operation actually runs.

And then there's the time cost. Every meeting where the consultant has to go research a regulatory question is a meeting your team could have been moving forward. Every misstep that has to be unwound during an audit is a week your launch slips.

FDA experience isn't just a credential — it changes how the system is configured, what data gets captured, and whether your workflows support your regulatory strategy or fight it.

An experienced implementer knows that lot traceability needs to extend through sterilization batches, not just stop at the work order. They know that electronic signatures need reason codes and that audit trails need to capture not just what changed but what the value was before and after. They know which standard reports an FDA investigator will ask for, and they configure the system so those reports exist on day one, not as a future enhancement.

Push vendors past their marketing material with specific questions about implementer experience:

Implementations led by teams with real FDA experience cost more on day one. They also cost less over five years, because you don't pay to undo the early decisions. You don't pay for the consultant who needed to learn on your project. You don't pay the remediation bill when an investigator finds the gaps an experienced team would have closed during configuration.

If you're choosing between a cheaper vendor whose team has never shipped a 510(k) and a more expensive vendor whose team has shipped fifty, the math almost always favors the second one. The cheaper bid is rarely the cheaper outcome.